Gwendolyn Quinn, PhD, from Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida College of Medicine, discusses fertility concerns among survivors of childhood cancer.
Gwendolyn Quinn, PhD, from Moffitt Cancer Center and professor of oncologic sciences at the University of South Florida College of Medicine, discusses fertility concerns among survivors of childhood cancer.
Fertility and reproductive health is the most important quality of life concern in survivors of adolescent and young adult cancer, Quinn says.
Over the past decade, several national organizations have issued guidelines urging oncology care providers to discuss potential threats of fertility with their patients and refer them to specialists.
FDA Approves Inotuzumab Ozogamicin for Pediatric Patients With ALL
March 6th 2024The antibody-drug conjugate inotuzumab ozogamicin was approved by the FDA for the treatment of patients aged 1 year and older with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.